COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 2383: Articles 23821-23830  | Next

Characterisation of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification
Baddock, H. T., Brolih, S., Yosaatmadja, Y., Ratnaweera, M., Bielinski, M., Swift, L., Cruz-Migoni, A., Morris, G. M., Schofield, C. J., Gileadi, O., McHugh, P. J.
10.1101/2020.08.13.248211 — Posted: 2020-08-13
The SARS-CoV-2 Spike harbours a lipid binding pocket which modulates stability of the prefusion trimer
Carrique, L., Duyvesteyn, H. M. E., Malinaukas, T., Zhao, Y., Ren, J., Zhou, D., Walter, T. S., Radecke, J., Huo, J., Ruza, R., Shah, P. N., Fry, E. E., Stuart, D. I.
10.1101/2020.08.13.249177 — Posted: 2020-08-13 Discussion: Onsite
Attenuated influenza virions expressing the SARS- CoV-2 receptor-binding domain induce neutralizing antibodies in mice
Loes, A. N., Gentles, L. E., Greaney, A. J., Crawford, K. H., Bloom, J. D.
10.1101/2020.08.12.248823 — Posted: 2020-08-13 Discussion: Onsite | Offsite
Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture
Risner, K., Tieu, K. V., Wang, Y., Bakovic, A., Bhalla, N., Nathan, S., Conway, D. E., Macklin, P., Narayanan, A.
10.1101/2020.08.12.246389 — Posted: 2020-08-13
Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load
Eskier, D., Suner, A., Oktay, Y., Karakülah, G.
10.1101/2020.08.12.248732 — Posted: 2020-08-13
Association of 25 hydroxyvitamin D concentration with risk of COVID-19: a Mendelian randomization study
Liu, D., Tian, Q., Zhang, J., Hou, H., Wang, W., Meng, Q., Wang, Y.
10.1101/2020.08.09.20171280 — Posted: 2020-08-13
The COVID-19 Pandemic Vulnerability Index (PVI) Dashboard: monitoring county level vulnerability
Marvel, S., House, J., Wheeler, M., Song, K., Zhou, Y., Wright, F., Chiu, W., Rusyn, I., Motsinger-Reif, A., Reif, D. M.
10.1101/2020.08.10.20169649 — Posted: 2020-08-13
Risk of fomite-mediated transmission of SARS-CoV-2 in child daycares, schools, and offices: a modeling study
Kraay, A. N. M., Hayashi, M. A. L., Berendes, D. M., Sobolik, J. S., Leon, J. S., Lopman, B. A.
10.1101/2020.08.10.20171629 — Posted: 2020-08-13
Deciphering the state of immune silence in fatal COVID-19 patients
Bost, P., De Sanctis, F., Cane, S., Ugel, S., Donadello, K., Castellucci, M., Eyal, D., Fiore, A., Anselmi, C., Barouni, R. M., Trovato, R., Caligola, S., Lamolinara, A., Iezzi, M., Facciotti, F., Mazzariol, A. R., Gibellini, D., De Nardo, P., Tacconelli, E., Gottin, L., Polati, E., Schwikowski, B., Amit, I., Bronte, V.
10.1101/2020.08.10.20170894 — Posted: 2020-08-13
A highly specific assay for the detection of SARS-CoV-2-reactive CD4+ and CD8+ T cells in COVID-19 patients
Zelba, H., Worbs, D., Harter, J., Pieper, N., Kyzirakos-Feger, C., Kayser, S., Seibold, M., Bartsch, O., Koedding, J., Biskup, S.
10.1101/2020.08.10.20150060 — Posted: 2020-08-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).